| 0 | ℹ |
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.
(linkinghub.elsevier.com)
|
The Lancet 2026-02-07 | #clinical trial #proteinuria #fsgs #podocyte #trpc6 |